Indogulf Cropsciences IPO subscribed 17% on Day 1: Check GMP, price band, and other key details
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
The initial public offering (IPO) of Indogulf Cropsciences was subscribed 17% by 12:15 pm on the first day of bidding on Thursday.The IPO received bids for 22,86,090 shares against the 1,33,65,710 shares on offer. Retail investors showed the highest interest, subscribing to 31% of their allotted quota. The non-institutional investor (NII) portion was subscribed 11%, while qualified institutional buyers (QIBs) were yet to participate.In the grey market, Indogulf shares were quoting a premium of Rs 10–11, suggesting an estimated upside of around 9% over the upper price band of the issue.Also Read: Street Favourite! 10 Nifty micro-cap stocks analysts expect to rally up to 60% The issue is open for subscription until June 30, with allotment expected on July 1 and listing tentatively scheduled on both BSE and NSE on July 3.The IPO is priced in the range of Rs 105 to Rs 111 per share. Investors can apply for a minimum of one lot comprising 135 shares, amounting to Rs 14,985 at the upper price band.Also Read: HDB Financial Services IPO: Should you subscribe? Here's what brokerages say Systematix Corporate Services is the book-running lead manager for the IPO, with Bigshare Services acting as the registrar. The issue has received keen interest across investor categories, supported by the company's strong fundamentals and diversified business operations.Established in 1993, Indogulf Cropsciences is a well-known player in the agrochemical industry. The company manufactures crop protection products, plant nutrients, and biologicals and has a strong presence across 22 Indian states, 3 Union Territories, and exports to 34 countries.Its robust infrastructure includes four manufacturing units in Haryana and Jammu & Kashmir, complemented by a large distribution network and 640 permanent employees.Also Read: These 10 multibagger penny stocks surged 200-570% in last 1 year. Do you own any? Financially, the company posted a revenue of Rs 555.79 crore in FY 2023–24 with a PAT of Rs 28.23 crore. It has demonstrated consistent performance with an EBITDA margin of over 10 percent and an ROE of 12.2%.The IPO proceeds will be used to fund working capital, repay debt, and establish a new dry flowable plant in Haryana.With its experienced promoters, strong R&D capabilities, and sectoral tailwinds from India's growing agri-input market, Indogulf Cropsciences IPO presents a promising investment opportunity for those seeking long-term value in the chemical and agri-tech space.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
2 minutes ago
- India.com
India's Pharma Exports Have Shot Up By 92% In Last 6 Years: Minister
New Delhi: Various schemes being implemented by the Centre to realise the vision of Aatmanirbhar Bharat in the pharmaceutical sector have resulted in India's exports of drugs and pharmaceuticals increasing by 92 per cent, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, the Parliament was informed on Friday. The schemes include the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme, the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, the PLI Scheme for Bulk Drugs, Scheme for Promotion of Bulk Drug Parks, and Strengthening of Pharmaceutical Industry scheme, Minister of State for Chemicals and Fertilisers Anupriya Patel told the Lok Sabha in a written reply to a question. The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India's Pharma MedTech sector from cost- to innovation-based growth by strengthening research and promoting industry-academia linkage for research and development in priority areas in drug discovery and development and medical devices. Under this scheme, seven Centres of Excellence (CoEs) have been set up, she said. The PLI Scheme for Pharmaceuticals aims to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high-value goods in the pharmaceutical sector. The minister said that the scheme has enabled enhanced investment and production in eligible products. As of March 2025, the committed investment of Rs 17,275 crore targeted over the six-year period of the scheme stands substantially exceeded with a cumulative investment of Rs 37,306 crore made by the scheme's third year, and cumulative sales of approved products of Rs 2,66,528 crore have been made, including exports of Rs 1,70,807 crore. The PLI Scheme for Bulk Drugs, which has a total budgetary outlay of Rs 6,940 crore, aims to avoid disruption in the supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs for which there are no alternatives by reducing supply disruption risk due to excessive dependence on a single source. As of March 2025, the committed investment of Rs 3,938.5 crore under projects approved under the scheme for investment over the six-year production period of the scheme stands substantially exceeded with a cumulative investment of Rs 4,570 crore made by the scheme's third year, she further stated. The minister also highlighted that the government launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme to make quality generic medicines available at affordable prices to all. Under the scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to provide medicines at prices that are about 50 per cent to 80 per cent lower than those of leading branded medicines in the market. Till June 6, 2025, a total of 16,912 JAKs have been opened, and on average, about 10 to 12 lakh persons visit these Kendras daily and avail of quality medicines at affordable prices. As many as 2,110 medicines and 315 surgicals, medical consumables and devices are under the scheme product basket, covering all major therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-allergic and gastro-intestinal medicines and nutraceuticals. As a result of the scheme, in the last 11 years, estimated savings of about Rs 38,000 crore have accrued to citizens in comparison to the prices of branded medicines. Further, the scheme has provided self-employment to over 16,000 persons, including over 6,800 women entrepreneurs, the minister added.
Hans India
2 minutes ago
- Hans India
DefMin signs Rs 2K-cr deal with BEL
New Delhi: The Ministry of Defence on Friday signed a contract with public-sector defence company Bharat Electronics Ltd (BEL) for the procurement of Air Defence Fire Control Radars for the Indian Army, worth approximately Rs2,000 crore, under the Buy (Indian-Indigenously Designed Developed and Manufactured) category. With a minimum 70 per cent indigenous content, these Fire Control Radars will be able to detect all forms of airborne threats, including fighter aircraft, attack helicopters and enemy drones. This would mark a significant milestone in the modernisation of the Air Defence Regiments and enhance the Indian Army's operational readiness, while contributing to the economic growth of the nation, according to a Defence Ministry statement. The contract was signed and exchanged by senior officials of the Ministry of Defence and BEL in the presence of Defence Secretary Rajesh Kumar Singh. The procurement marks a pivotal step towards empowering indigenous defence industries by encouraging Indian MSMEs through components manufacturing and raw material supply, the statement said. The government is keen to promote the country's defence industry, and earlier this month Defence Acquisition Council, under the chairmanship of Defence Minister Rajnath Singh, gave the go-ahead for 10 proposals to purchase military hardware, including missiles and electronic warfare systems, worth approximately Rs 1.05 lakh crore through indigenous sourcing. India's indigenous defence production has surged to an all-time high of Rs1.46 lakh crore, with exports increasing to a record Rs24,000 crore in 2024-25, according to Defence Minister Rajnath Singh.'Our defence production, which was only Rs43,000 crore 10 to 11 years ago, has now crossed a record figure of Rs1,46,000 crore, with the private sector's contribution of over Rs32,000 crore. Our defence exports, which were around Rs600-700 crore 10 years ago, have surpassed a record figure of Rs24,000 crore today,' the minister stated in his address at the Confederation of Indian Industry (CII) annual summit recently. He described Make-in-India as crucial for security and prosperity, stating that the use of indigenous systems during Operation Sindoor has proved that India has the power to penetrate any armour of the enemy.
The Hindu
2 minutes ago
- The Hindu
What happened to the crypto exchange CoinDCX?
The story so far: On July 19, the crypto exchange CoinDCX updated users that one of its internal accounts had been 'compromised.' The company's executives reassured panicked investors and traders that their assets were safe and that access to their crypto would not be cut off. Despite assurances, many CoinDCX customers moved to withdraw their assets, perceiving the event could turn into something like the WazirX hack last year. What happened to CoinDCX? CoinDCX is a Financial Intelligence Unit (FIU) registered Indian cryptocurrency exchange founded in 2018 by Neeraj Khandelwal and Sumit Gupta, now counting over 1.6 crore registered users. On July 19, the exchange shared that one of its 'internal operational accounts, used solely for liquidity provisioning on a partner exchange, was compromised due to a sophisticated server breach.' Mr. Khandelwal clarified this involved unauthorised access to an operational hot (virtually connected) wallet on a partner exchange. CoinDCX reported financial exposure of about $44 million but stressed that the incident was contained by isolating the affected account, which was segregated from the company's customer wallets. The exchange further added that the exposure was limited to that amount alone and that it would be fully absorbed by CoinDCX through its own reserves. 'The incident has been formally reported to CERT-In, and we are actively working with leading blockchain forensics firms and ecosystem partners to trace the attacker and recover assets,' said CoinDCX in its Incident Report, and provided information about the cross-chain movement of the stolen assets. The company also announced a recovery bounty programme. How were CoinDCX users impacted by the hack? CoinDCX repeatedly stressed that customers' funds were secure and unaffected by the hack, as they were placed in segregated, cold wallets that are challenging for attackers to breach. The company also stated that trading, rupee deposits, and rupee withdrawals remained fully functional throughout the period. However, some customers complained that their withdrawal requests took time to be processed, sparking fears that their funds had been frozen. CoinDCX's founding partner Mridul Gupta said that 'operational challenges caused by high withdrawal volumes during non-banking hours' had led to some delays but denied allegations of a freeze. The company later confirmed that all withdrawal requests had been successfully processed. While crypto withdrawals are not possible for everyone using CoinDCX, this is a pre-existing situation that is part of the company's risk policy and was not caused by the hack itself. Furthermore, the exchange faced accusations of a 17-hour-long delay when it came to updating customers about the hack. CoinDCX defended its actions and said it needed to have all the information before issuing a statement to customers but said investigating agencies were immediately informed and onboarded. 'Our first priority is always to act, not just to speak. Before making a public statement, we had to ensure the threat was fully contained, our platform was secure, and all customer funds were safe. Communicating with incomplete or unverified information would have been irresponsible and could have caused unnecessary panic,' said co-founder Sumit Gupta. Other CoinDCX users raised complaints about temporary price drops for certain assets, as well as some tokens being under maintenance, which the company also addressed. How are the CoinDCX and WazirX hacks different? Just a little over a year ago, on July 18, 2024, WazirX was targeted by North Korean cyber-thieves. That day, a multi-signature wallet that the WazirX exchange was managing with the company Liminal was exploited, leading to the loss of assets worth over $230 million. This was far greater than the losses reported by CoinDCX; WazirX customers' assets were directly affected by this breach. After much delay and confusion, WazirX blocked users' access to their crypto for an indefinite period of time and acknowledged significant losses. By contrast, CoinDCX has stressed that it is business as usual for the exchange, noting on X that its annual revenue exceeds ₹1,100 crores. WazirX customers demanded that the company use its own profits or funds to cover losses, but the company said this was not possible, citing an ownership dispute with the international crypto exchange Binance. WazirX further decided to carry out its legal restructuring exercise in Singapore. WazirX users have not been able to access their locked up crypto for over a year and are set to vote for a second time on the amended Scheme of Arrangement. This comes after the first proposed restructuring plan was rejected by the Singapore High Court. Both WazirX and CoinDCX were hit with criticism for delays in informing their customers about their respective hacks. What is the lesson for crypto investors in India? Investors in India should remember that crypto trading is a largely unregulated activity in the country; even users of centralised, FIU-registered exchanges can expect little to no support from the Indian authorities in case of a crisis such as a security breach. Satnam Narang, Senior Staff Research Engineer at Tenable, explained that if users want full control of their coins, they should consider self-custody options like an offline, hardware cold wallet they directly control. Even here, due diligence is required in order to buy only trusted hardware wallets from legitimate sellers, according to him. 'As more and more exchanges have been set up across the world, we have seen reports of attacks targeting smart contract flaws or other ways to steal funds from these exchanges including but not limited to social engineering, theft of credentials or private keys or targeting a third-party company that works with the targeted organization,' said Mr. Narang, noting that the CoinDCX hack was one of the largest cryptocurrency breaches since the attack against WazirX last year. He highlighted that when crypto prices go up, there is also a rise in attacks against both exchanges and customers. Mr. Narang said that traders storing coins on crypto exchanges should use multi-factor authentication and strong passwords, or store their coins securely offline, if possible. 'There is an old adage in the cryptocurrency space that says: 'not your keys, not your crypto/coins'. As long as users store their cryptocurrency on an exchange, those coins don't necessarily belong to them because the exchange could ban their account or an exchange hack could lead to the loss of coins,' explained Mr. Narang.
